1. Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
   Sajad Fakhri et al, 2022, Biochemical Pharmacology CrossRef
2. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
   Lorenzo Homann et al, 2022, Cells CrossRef
3. Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21
   Matthew D. Shortridge et al, 2023, ACS Chem. Biol. CrossRef
4. Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention
   Maria A. Zamkova et al, 2023, Biochemistry Moscow CrossRef
5. Research Progress of CDK4/6 Inhibitors in Digestive Tract Tumors
   ·斯提瓦尔地 伊丽达娜, 2023, ACM CrossRef
6. Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy
   Angel Cayo et al, 2023, IJMS CrossRef
7. Mesoporous polydopamine Targeting CDK4/6 Inhibitor toward Brilliant Synergistic Immunotherapy of Breast Cancer
   Conglei Zhou et al, 2024, Small CrossRef
8. Therapy induced tumor cell senescence: mechanisms and ways to overcome
   M. A Zamkova et al, 2023, Biohimiâ CrossRef
9. Comprehensive analysis of CPNE1 predicts prognosis and drug resistance in gastric adenocarcinoma
   Guangyao Li, 2024, Am J Transl Res CrossRef
10. CDK4/6 inhibition initiates cell cycle arrest by nuclear translocation of RB and induces a multistep molecular response
    Ting Hong et al, 2024, Cell Death Discov. CrossRef
11. TFAP2C-DDR1 Axis Regulates Resistance to CDK4/6 Inhibitor in Breast Cancer
    Muhammad Jameel Mughal et al, 2024, Cancer Letters CrossRef
12. Senolytics: charting a new course or enhancing existing anti-tumor therapies?
    Konrad Czajkowski et al, 2024, Cell Oncol. CrossRef
13. Self-assembled natural triterpenoids for the delivery of cyclin-dependent kinase 4/6 inhibitors to enhance cancer chemoimmunotherapy
    Yongbo Zhang et al, 2025, Journal of Controlled Release CrossRef